James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 1,382 shares at $140.72 ($194K) on 2024-06-03, disclosed to the SEC on 2024-06-04.
Scheduled sale ($194k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.72 | 691 | $97K | 50.0% |
| 2 | $140.72 | 691 | $97K | 50.0% |
| Total | $140.72 avg | 1,382 | $194K | 100% |
| Filing → |
| MRNA | SELL | 2024-10-08 | $43K | — | Filing → |
| MRNA | SELL | 2024-08-30 | $13K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |